Importance of idiopathic pulmonary fibrosis staging for clinical trial endpoints
- PMID: 23725620
- DOI: 10.1164/rccm.201208-1555LE
Importance of idiopathic pulmonary fibrosis staging for clinical trial endpoints
Comment in
-
Reply: idiopathic pulmonary fibrosis: perspectives on clinically meaningful primary endpoints in phase 3 clinical trials.Am J Respir Crit Care Med. 2013 Jun 1;187(11):1272. doi: 10.1164/rccm.201304-0712LE. Am J Respir Crit Care Med. 2013. PMID: 23725623 No abstract available.
Comment on
-
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials.Am J Respir Crit Care Med. 2012 May 15;185(10):1044-8. doi: 10.1164/rccm.201201-0006PP. Epub 2012 Apr 13. Am J Respir Crit Care Med. 2012. PMID: 22505745 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
